When people think about treatment options after receiving a lung cancer diagnosis, they often don’t think about clinical trials. In fact, many people are fearful of exploring clinical trials and may shy away from discussing them with their care [...]
Clinical Trial Aims to Unlock the Origins of Lung Cancer WASHINGTON and BOSTON, April 17, 2024 – In a promising step forward, GO2 for Lung Cancer (GO2), Dana-Farber Cancer Institute (Dana-Farber), and the Addario Lung Cancer Medical Institute (ALCMI), [...]
Clinical trials are a critical part of developing future treatments for lung cancer and other diseases, but low enrollment indicates that they are also often misunderstood by people who might benefit from them. In June’s Lung Cancer Living Room, [...]
By Daniel A. Saez, M.Sc., Treatment and Trials Navigator, GO2 for Lung Cancer Patients often hear the words clinical trial and don’t know what to expect or sometimes even what a clinical trial is. GO2 for Lung Cancer has [...]
Increasing diversity within lung cancer clinical trials is of critical importance for patients, caregivers, and researchers. To make sure that you are informed and prepared to share the message, we’ve pulled together some helpful blog posts and downloadable materials [...]